Anne Borgman

Insider Reports History

Entity
Individual
Location
9000 Virginia Manor Road, Suite 200, Beltsville, MD
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Anne Borgman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Borgman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. CHIEF MEDICAL OFFICER Restricted Stock Unit (RSU) 113K $561K $4.99 Feb 29, 2024 Direct
SUTRO BIOPHARMA, INC. CHIEF MEDICAL OFFICER Restricted Stock Units (RSUs) 45K $204K $4.54 Mar 5, 2024 Direct
SUTRO BIOPHARMA, INC. CHIEF MEDICAL OFFICER Common Stock 24.4K $120K $4.91 Feb 29, 2024 Direct
CURIS INC Director Non Qualified Stock Option 4.25K $49.4K $11.62 May 21, 2024 Direct
SUTRO BIOPHARMA, INC. CHIEF MEDICAL OFFICER Stock Option (Right to Buy Common Stock) 60K Mar 5, 2024 Direct
NextCure, Inc. Director Stock Option (Right to Buy) 18.7K Jun 20, 2024 Direct

Insider Reports Filed by Anne Borgman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NXTC NextCure, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
CRIS CURIS INC May 21, 2024 1 $49.4K 4 May 23, 2024 Director
STRO SUTRO BIOPHARMA, INC. Mar 5, 2024 2 $0 4 Mar 7, 2024 CHIEF MEDICAL OFFICER
STRO SUTRO BIOPHARMA, INC. Feb 29, 2024 3 -$64.4K 4 Mar 4, 2024 CHIEF MEDICAL OFFICER
NXTC NextCure, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
STRO SUTRO BIOPHARMA, INC. Mar 15, 2023 2 $0 4 Mar 17, 2023 Chief Medical Officer
STRO SUTRO BIOPHARMA, INC. Feb 28, 2023 0 $0 3 Mar 7, 2023 Chief Medical Officer
CRIS CURIS INC Jan 23, 2023 1 $0 4 Jan 24, 2023 Director
CRIS CURIS INC Oct 12, 2022 1 $0 4 Oct 14, 2022 Director
CRIS CURIS INC Oct 12, 2022 0 $0 3 Oct 14, 2022 Director
NXTC NextCure, Inc. Jun 23, 2022 1 $0 4 Jun 24, 2022 Director
NXTC NextCure, Inc. Oct 1, 2021 2 $0 4 Oct 5, 2021 Director
NXTC NextCure, Inc. Oct 1, 2021 0 $0 3 Oct 5, 2021 Director